Borui Pharmaceutical (688166.SH) subsidiary obtained tiotropium bromide odaterol inhalation spray drug registration certificate

Zhitongcaijing · 2d ago

Zhitong Finance App News, Borui Pharmaceutical (688166.SH) issued an announcement. Recently, Atmy (Suzhou) Pharmaceutical Technology Co., Ltd., a holding subsidiary of the company, received the “tiotropium bromide odatrol inhalation spray” and “drug registration certificate” issued by the State Drug Administration. This drug is suitable for long-term maintenance treatment of patients with chronic obstructive pulmonary disease (COPD, COPD, including chronic bronchitis and emphysema) to relieve symptoms. The approved listing has further enriched the company's respiratory product pipeline and is conducive to enhancing the market competitiveness of the company's products.